SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2wsx'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FXH_B_PACB1001_0 (PENICILLIN ACYLASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	MET A 408 PHE A 411 SER A 109 ILE A 395	None	0.81A	1fxhA-2wsxA: undetectable 1fxhB-2wsxA: undetectable	1fxhA-2wsxA: 18.43 1fxhB-2wsxA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NT6_A_DVAA6_0 (GRAMICIDIN C)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	ALA A 418 VAL A 420 TRP A 239	None	0.85A	1nt6A-2wsxA: undetectable	1nt6A-2wsxA: 6.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NT6_B_DVAB6_0 (GRAMICIDIN C)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	ALA A 418 VAL A 420 TRP A 239	None	0.85A	1nt6B-2wsxA: undetectable	1nt6B-2wsxA: 6.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1O86_A_LPRA702_2 (ANGIOTENSIN CONVERTING ENZYME)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 4	SER A 109 VAL A 104 PHE A 411 VAL A 273	None	1.45A	1o86A-2wsxA: 2.6	1o86A-2wsxA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PNL_B_PACB559_0 (PENICILLIN AMIDOHYDROLASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 8	MET A 408 PHE A 411 SER A 109 ILE A 395	None	0.85A	1pnlA-2wsxA: 0.7 1pnlB-2wsxA: undetectable	1pnlA-2wsxA: 18.43 1pnlB-2wsxA: 22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T46_A_STIA3_2 (HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	VAL A 448 VAL A 247 ARG A 170 CYH A 426	None	1.10A	1t46A-2wsxA: undetectable	1t46A-2wsxA: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XVA_A_ACTA294_0 (GLYCINE N-METHYLTRANSFERASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 5	TRP A 239 ILE A 235 LEU A 208 ALA A 211	None	0.99A	1xvaA-2wsxA: undetectable 1xvaB-2wsxA: undetectable	1xvaA-2wsxA: 20.85 1xvaB-2wsxA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XVA_B_ACTB294_0 (GLYCINE N-METHYLTRANSFERASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 6	ALA A 211 TRP A 239 ILE A 235 LEU A 208	None	1.04A	1xvaA-2wsxA: undetectable 1xvaB-2wsxA: undetectable	1xvaA-2wsxA: 20.85 1xvaB-2wsxA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2D55_C_DVAC2_0 (ACTINOMYCIN D)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	THR A 118 PRO A 120 PRO A 125	None	0.89A	2d55C-2wsxA: undetectable	2d55C-2wsxA: 2.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2D55_C_DVAC8_0 (ACTINOMYCIN D)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	PRO A 125 THR A 118 PRO A 120	None	0.67A	2d55C-2wsxA: undetectable	2d55C-2wsxA: 2.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FK8_A_SAMA302_1 (METHOXY MYCOLIC ACID SYNTHASE 4)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	SER A 173 THR A 429 GLN A 330	None	0.85A	2fk8A-2wsxA: undetectable	2fk8A-2wsxA: 20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QMZ_A_LDPA501_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	GLY A 451 PHE A 15 ILE A 10 PHE A 16	None	0.95A	2qmzA-2wsxA: undetectable 2qmzB-2wsxA: undetectable	2qmzA-2wsxA: 18.48 2qmzB-2wsxA: 18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XRZ_B_ACTB1463_0 (DEOXYRIBODIPYRIMIDIN E PHOTOLYASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 7	VAL A 47 ILE A 477 ALA A 322 GLY A 52 THR A 48	None	1.11A	2xrzB-2wsxA: undetectable	2xrzB-2wsxA: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3APW_A_DP0A190_1 (ALPHA-1-ACID GLYCOPROTEIN 2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	TYR A 285 ILE A 374 PHE A 312 ALA A 136 SER A 289	None	1.38A	3apwA-2wsxA: undetectable	3apwA-2wsxA: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_H_SVRH504_3 (PHOSPHOLIPASE A2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 11	LEU A 268 GLY A 271 ILE A 275 PRO A 402 THR A 407	None	1.33A	3bjwH-2wsxA: undetectable	3bjwH-2wsxA: 10.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CR5_X_PNTX95_0 (PROTEIN S100-B)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	CYH A 481 PHE A 484 PHE A 485	None	0.80A	3cr5X-2wsxA: 0.8	3cr5X-2wsxA: 9.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E9X_A_NIMA1_1 (LACTOTRANSFERRIN')	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 4	GLU A 124 GLY A 129 THR A 128 GLU A 132	None	0.97A	3e9xA-2wsxA: undetectable	3e9xA-2wsxA: 19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_C_CHDC151_0 (ILEAL BILE ACID-BINDING PROTEIN)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 10	ILE A 476 ILE A 477 VAL A 47 GLY A 52 TYR A 58	None	1.03A	3elzC-2wsxA: undetectable	3elzC-2wsxA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_A_CELA682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 79 ALA A 148 VAL A 70 GLY A 72 ALA A 75	None	1.05A	3ln1A-2wsxA: 1.9	3ln1A-2wsxA: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_B_CELB682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 79 ALA A 148 VAL A 70 GLY A 72 ALA A 75	None	1.05A	3ln1B-2wsxA: 1.0	3ln1B-2wsxA: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_C_CELC682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 79 ALA A 148 VAL A 70 GLY A 72 ALA A 75	None	1.05A	3ln1C-2wsxA: undetectable	3ln1C-2wsxA: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_D_CELD682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 79 ALA A 148 VAL A 70 GLY A 72 ALA A 75	None	1.05A	3ln1D-2wsxA: undetectable	3ln1D-2wsxA: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUF_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	PHE A 312 HIS A 141 ILE A 476 GLY A 315 ALA A 322	None None None NM2 A1505 (-2.5A) None	0.93A	3sufB-2wsxA: undetectable	3sufB-2wsxA: 17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UFN_A_ROCA401_2 (HIV-1 PROTEASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	ASP A 193 VAL A 179 VAL A 486 VAL A 192	None	0.79A	3ufnB-2wsxA: undetectable	3ufnB-2wsxA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UNA_A_SALA1340_1 (XANTHINE DEHYDROGENASE/OXIDAS E)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 9	LEU A 265 SER A 266 THR A 100 LEU A 105 ALA A 418	None	1.45A	3unaA-2wsxA: 1.2	3unaA-2wsxA: 16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UNA_B_SALB1340_1 (XANTHINE DEHYDROGENASE/OXIDAS E)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 9	LEU A 265 SER A 266 THR A 100 LEU A 105 ALA A 418	None	1.44A	3unaB-2wsxA: undetectable	3unaB-2wsxA: 16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WIP_J_ACHJ301_0 (ACETYLCHOLINE-BINDIN G PROTEIN)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 8	LEU A 301 MET A 300 TYR A 115 THR A 317	None	1.18A	3wipF-2wsxA: undetectable 3wipJ-2wsxA: undetectable	3wipF-2wsxA: 17.91 3wipJ-2wsxA: 17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OK1_A_198A1001_1 (ANDROGEN RECEPTOR)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 403 LEU A 268 MET A 269 VAL A 273 ILE A 413	None	1.06A	4ok1A-2wsxA: undetectable	4ok1A-2wsxA: 18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKB_A_198A1002_1 (ANDROGEN RECEPTOR)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 403 LEU A 268 MET A 269 VAL A 273 ILE A 413	None	1.03A	4okbA-2wsxA: undetectable	4okbA-2wsxA: 18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RTB_A_SAMA501_0 (HYDG PROTEIN)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	VAL A 273 ASN A 369 LEU A 372 LEU A 135 LEU A 139	None	1.44A	4rtbA-2wsxA: undetectable	4rtbA-2wsxA: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TZU_B_Y70B505_1 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	HIS A 141 TRP A 324 TRP A 147 TRP A 142	None NM2 A1504 ( 4.6A) None None	1.42A	4tzuB-2wsxA: undetectable 4tzuC-2wsxA: undetectable	4tzuB-2wsxA: 13.79 4tzuC-2wsxA: 13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TZU_C_Y70C504_1 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	TRP A 142 HIS A 141 TRP A 324 TRP A 147	None None NM2 A1504 ( 4.6A) None	1.42A	4tzuB-2wsxA: undetectable 4tzuC-2wsxA: undetectable	4tzuB-2wsxA: 13.79 4tzuC-2wsxA: 13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZDY_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	ALA A 156 TYR A 159 PRO A 177	None	0.66A	4zdyA-2wsxA: undetectable	4zdyA-2wsxA: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESF_A_TPFA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 8	ILE A 326 TYR A 327 PHE A 319 LEU A 210	None NM2 A1504 (-4.4A) None None	0.88A	5esfA-2wsxA: undetectable	5esfA-2wsxA: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JW1_B_CELB602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	LEU A 79 ALA A 148 VAL A 70 GLY A 72 ALA A 75	None	1.02A	5jw1B-2wsxA: undetectable	5jw1B-2wsxA: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_2 (CYCLIN-DEPENDENT KINASE 6)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	LYS A 77 GLN A 500 ASN A 501	None	0.92A	5l2tA-2wsxA: undetectable	5l2tA-2wsxA: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND3_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	VAL A 352 LEU A 297 LEU A 145 ALA A 148 SER A 151	None	1.11A	5nd3B-2wsxA: undetectable	5nd3B-2wsxA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND7_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 12	VAL A 352 LEU A 297 LEU A 145 ALA A 148 SER A 151	None	1.05A	5nd7B-2wsxA: undetectable	5nd7B-2wsxA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X23_A_LSNA502_2 (CYTOCHROME P450 2C9)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	3 / 3	LEU A 483 VAL A 192 ASP A 193	None	0.59A	5x23A-2wsxA: undetectable	5x23A-2wsxA: 20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YIZ_K_EF2K501_1 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	HIS A 141 TRP A 324 TRP A 147 TRP A 142	None NM2 A1504 ( 4.6A) None None	1.47A	5yizk-2wsxA: undetectable 5yizt-2wsxA: undetectable	5yizk-2wsxA: 9.69 5yizt-2wsxA: 9.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YIZ_Y_EF2Y501_1 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	TRP A 142 HIS A 141 TRP A 324 TRP A 147	None None NM2 A1504 ( 4.6A) None	1.49A	5yizG-2wsxA: undetectable 5yizY-2wsxA: undetectable	5yizG-2wsxA: 9.69 5yizY-2wsxA: 9.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJ0_K_EF2K501_1 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	HIS A 141 TRP A 324 TRP A 147 TRP A 142	None NM2 A1504 ( 4.6A) None None	1.49A	5yj0k-2wsxA: undetectable 5yj0t-2wsxA: undetectable	5yj0k-2wsxA: 9.69 5yj0t-2wsxA: 9.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJ1_K_6ELK501_0 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 7	HIS A 141 TRP A 324 TRP A 147 TRP A 142	None NM2 A1504 ( 4.6A) None None	1.49A	5yj1k-2wsxA: undetectable 5yj1t-2wsxA: undetectable	5yj1k-2wsxA: 12.84 5yj1t-2wsxA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJ1_T_6ELT501_0 (PROTEIN CEREBLON)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	4 / 8	TRP A 142 HIS A 141 TRP A 324 TRP A 147	None None NM2 A1504 ( 4.6A) None	1.43A	5yj1k-2wsxA: undetectable 5yj1t-2wsxA: undetectable	5yj1k-2wsxA: 12.84 5yj1t-2wsxA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZJI_A_PQNA844_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1 PHOTOSYSTEM I REACTION CENTER SUBUNIT IX)	2wsx	L-CARNITINE/GAMMA-BU TYROBETAINE ANTIPORTER (Escherichia coli)	5 / 10	PHE A 286 GLY A 291 ALA A 136 LEU A 139 PHE A 411	None	1.44A	5zjiA-2wsxA: undetectable 5zjiJ-2wsxA: undetectable	5zjiA-2wsxA: 9.48 5zjiJ-2wsxA: 7.01

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FXH_B_PACB1001_0","PENICILLIN ACYLASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"MET A 408;PHE A 411;SER A 109;ILE A 395","None","0.81A","1fxhA-2wsxA:undetectable;1fxhB-2wsxA:undetectable","1fxhA-2wsxA:18.43;1fxhB-2wsxA:22.22"],["1NT6_A_DVAA6_0","GRAMICIDIN C","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"ALA A 418;VAL A 420;TRP A 239","None","0.85A","1nt6A-2wsxA:undetectable","1nt6A-2wsxA:6.19"],["1NT6_B_DVAB6_0","GRAMICIDIN C","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"ALA A 418;VAL A 420;TRP A 239","None","0.85A","1nt6B-2wsxA:undetectable","1nt6B-2wsxA:6.19"],["1O86_A_LPRA702_2","ANGIOTENSIN CONVERTING ENZYME","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"SER A 109;VAL A 104;PHE A 411;VAL A 273","None","1.45A","1o86A-2wsxA:2.6","1o86A-2wsxA:21.10"],["1PNL_B_PACB559_0","PENICILLIN AMIDOHYDROLASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"MET A 408;PHE A 411;SER A 109;ILE A 395","None","0.85A","1pnlA-2wsxA:0.7;1pnlB-2wsxA:undetectable","1pnlA-2wsxA:18.43;1pnlB-2wsxA:22.05"],["1T46_A_STIA3_2","HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"VAL A 448;VAL A 247;ARG A 170;CYH A 426","None","1.10A","1t46A-2wsxA:undetectable","1t46A-2wsxA:20.50"],["1XVA_A_ACTA294_0","GLYCINE N-METHYLTRANSFERASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"TRP A 239;ILE A 235;LEU A 208;ALA A 211","None","0.99A","1xvaA-2wsxA:undetectable;1xvaB-2wsxA:undetectable","1xvaA-2wsxA:20.85;1xvaB-2wsxA:20.85"],["1XVA_B_ACTB294_0","GLYCINE N-METHYLTRANSFERASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"ALA A 211;TRP A 239;ILE A 235;LEU A 208","None","1.04A","1xvaA-2wsxA:undetectable;1xvaB-2wsxA:undetectable","1xvaA-2wsxA:20.85;1xvaB-2wsxA:20.85"],["2D55_C_DVAC2_0","ACTINOMYCIN D","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"THR A 118;PRO A 120;PRO A 125","None","0.89A","2d55C-2wsxA:undetectable","2d55C-2wsxA:2.35"],["2D55_C_DVAC8_0","ACTINOMYCIN D","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"PRO A 125;THR A 118;PRO A 120","None","0.67A","2d55C-2wsxA:undetectable","2d55C-2wsxA:2.35"],["2FK8_A_SAMA302_1","METHOXY MYCOLIC ACID SYNTHASE 4","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"SER A 173;THR A 429;GLN A 330","None","0.85A","2fk8A-2wsxA:undetectable","2fk8A-2wsxA:20.84"],["2QMZ_A_LDPA501_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE;RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"GLY A 451;PHE A  15;ILE A  10;PHE A  16","None","0.95A","2qmzA-2wsxA:undetectable;2qmzB-2wsxA:undetectable","2qmzA-2wsxA:18.48;2qmzB-2wsxA:18.48"],["2XRZ_B_ACTB1463_0","DEOXYRIBODIPYRIMIDINE PHOTOLYASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"VAL A  47;ILE A 477;ALA A 322;GLY A  52;THR A  48","None","1.11A","2xrzB-2wsxA:undetectable","2xrzB-2wsxA:21.48"],["3APW_A_DP0A190_1","ALPHA-1-ACID GLYCOPROTEIN 2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"TYR A 285;ILE A 374;PHE A 312;ALA A 136;SER A 289","None","1.38A","3apwA-2wsxA:undetectable","3apwA-2wsxA:14.76"],["3BJW_H_SVRH504_3","PHOSPHOLIPASE A2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A 268;GLY A 271;ILE A 275;PRO A 402;THR A 407","None","1.33A","3bjwH-2wsxA:undetectable","3bjwH-2wsxA:10.50"],["3CR5_X_PNTX95_0","PROTEIN S100-B","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"CYH A 481;PHE A 484;PHE A 485","None","0.80A","3cr5X-2wsxA:0.8","3cr5X-2wsxA:9.72"],["3E9X_A_NIMA1_1","LACTOTRANSFERRIN'","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"GLU A 124;GLY A 129;THR A 128;GLU A 132","None","0.97A","3e9xA-2wsxA:undetectable","3e9xA-2wsxA:19.81"],["3ELZ_C_CHDC151_0","ILEAL BILE ACID-BINDING PROTEIN","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"ILE A 476;ILE A 477;VAL A  47;GLY A  52;TYR A  58","None","1.03A","3elzC-2wsxA:undetectable","3elzC-2wsxA:14.29"],["3LN1_A_CELA682_1","PROSTAGLANDIN G\/H SYNTHASE 2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A  79;ALA A 148;VAL A  70;GLY A  72;ALA A  75","None","1.05A","3ln1A-2wsxA:1.9","3ln1A-2wsxA:22.89"],["3LN1_B_CELB682_1","PROSTAGLANDIN G\/H SYNTHASE 2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A  79;ALA A 148;VAL A  70;GLY A  72;ALA A  75","None","1.05A","3ln1B-2wsxA:1.0","3ln1B-2wsxA:22.89"],["3LN1_C_CELC682_1","PROSTAGLANDIN G\/H SYNTHASE 2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A  79;ALA A 148;VAL A  70;GLY A  72;ALA A  75","None","1.05A","3ln1C-2wsxA:undetectable","3ln1C-2wsxA:22.89"],["3LN1_D_CELD682_1","PROSTAGLANDIN G\/H SYNTHASE 2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A  79;ALA A 148;VAL A  70;GLY A  72;ALA A  75","None","1.05A","3ln1D-2wsxA:undetectable","3ln1D-2wsxA:22.89"],["3SUF_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"PHE A 312;HIS A 141;ILE A 476;GLY A 315;ALA A 322","None;None;None;NM2 A1505 (-2.5A);None","0.93A","3sufB-2wsxA:undetectable","3sufB-2wsxA:17.74"],["3UFN_A_ROCA401_2","HIV-1 PROTEASE;HIV-1 PROTEASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"ASP A 193;VAL A 179;VAL A 486;VAL A 192","None","0.79A","3ufnB-2wsxA:undetectable","3ufnB-2wsxA:12.37"],["3UNA_A_SALA1340_1","XANTHINE DEHYDROGENASE\/OXIDASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A 265;SER A 266;THR A 100;LEU A 105;ALA A 418","None","1.45A","3unaA-2wsxA:1.2","3unaA-2wsxA:16.93"],["3UNA_B_SALB1340_1","XANTHINE DEHYDROGENASE\/OXIDASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A 265;SER A 266;THR A 100;LEU A 105;ALA A 418","None","1.44A","3unaB-2wsxA:undetectable","3unaB-2wsxA:16.93"],["3WIP_J_ACHJ301_0","ACETYLCHOLINE-BINDING PROTEIN","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"LEU A 301;MET A 300;TYR A 115;THR A 317","None","1.18A","3wipF-2wsxA:undetectable;3wipJ-2wsxA:undetectable","3wipF-2wsxA:17.91;3wipJ-2wsxA:17.91"],["4OK1_A_198A1001_1","ANDROGEN RECEPTOR","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A 403;LEU A 268;MET A 269;VAL A 273;ILE A 413","None","1.06A","4ok1A-2wsxA:undetectable","4ok1A-2wsxA:18.80"],["4OKB_A_198A1002_1","ANDROGEN RECEPTOR","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A 403;LEU A 268;MET A 269;VAL A 273;ILE A 413","None","1.03A","4okbA-2wsxA:undetectable","4okbA-2wsxA:18.80"],["4RTB_A_SAMA501_0","HYDG PROTEIN","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"VAL A 273;ASN A 369;LEU A 372;LEU A 135;LEU A 139","None","1.44A","4rtbA-2wsxA:undetectable","4rtbA-2wsxA:22.39"],["4TZU_B_Y70B505_1","PROTEIN CEREBLON;PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"HIS A 141;TRP A 324;TRP A 147;TRP A 142","None;NM2 A1504 ( 4.6A);None;None","1.42A","4tzuB-2wsxA:undetectable;4tzuC-2wsxA:undetectable","4tzuB-2wsxA:13.79;4tzuC-2wsxA:13.79"],["4TZU_C_Y70C504_1","PROTEIN CEREBLON;PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"TRP A 142;HIS A 141;TRP A 324;TRP A 147","None;None;NM2 A1504 ( 4.6A);None","1.42A","4tzuB-2wsxA:undetectable;4tzuC-2wsxA:undetectable","4tzuB-2wsxA:13.79;4tzuC-2wsxA:13.79"],["4ZDY_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"ALA A 156;TYR A 159;PRO A 177","None","0.66A","4zdyA-2wsxA:undetectable","4zdyA-2wsxA:22.71"],["5ESF_A_TPFA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"ILE A 326;TYR A 327;PHE A 319;LEU A 210","None;NM2 A1504 (-4.4A);None;None","0.88A","5esfA-2wsxA:undetectable","5esfA-2wsxA:22.45"],["5JW1_B_CELB602_1","PROSTAGLANDIN G\/H SYNTHASE 2","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"LEU A  79;ALA A 148;VAL A  70;GLY A  72;ALA A  75","None","1.02A","5jw1B-2wsxA:undetectable","5jw1B-2wsxA:22.71"],["5L2T_A_6ZZA900_2","CYCLIN-DEPENDENT KINASE 6","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"LYS A  77;GLN A 500;ASN A 501","None","0.92A","5l2tA-2wsxA:undetectable","5l2tA-2wsxA:20.04"],["5ND3_B_TA1B601_1","TUBULIN BETA-2B CHAIN","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"VAL A 352;LEU A 297;LEU A 145;ALA A 148;SER A 151","None","1.11A","5nd3B-2wsxA:undetectable","5nd3B-2wsxA:20.91"],["5ND7_B_TA1B601_1","TUBULIN BETA-2B CHAIN","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"VAL A 352;LEU A 297;LEU A 145;ALA A 148;SER A 151","None","1.05A","5nd7B-2wsxA:undetectable","5nd7B-2wsxA:20.91"],["5X23_A_LSNA502_2","CYTOCHROME P450 2C9","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",3,"LEU A 483;VAL A 192;ASP A 193","None","0.59A","5x23A-2wsxA:undetectable","5x23A-2wsxA:20.57"],["5YIZ_K_EF2K501_1","PROTEIN CEREBLON;PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"HIS A 141;TRP A 324;TRP A 147;TRP A 142","None;NM2 A1504 ( 4.6A);None;None","1.47A","5yizk-2wsxA:undetectable;5yizt-2wsxA:undetectable","5yizk-2wsxA:9.69;5yizt-2wsxA:9.69"],["5YIZ_Y_EF2Y501_1","PROTEIN CEREBLON;PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"TRP A 142;HIS A 141;TRP A 324;TRP A 147","None;None;NM2 A1504 ( 4.6A);None","1.49A","5yizG-2wsxA:undetectable;5yizY-2wsxA:undetectable","5yizG-2wsxA:9.69;5yizY-2wsxA:9.69"],["5YJ0_K_EF2K501_1","PROTEIN CEREBLON;PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"HIS A 141;TRP A 324;TRP A 147;TRP A 142","None;NM2 A1504 ( 4.6A);None;None","1.49A","5yj0k-2wsxA:undetectable;5yj0t-2wsxA:undetectable","5yj0k-2wsxA:9.69;5yj0t-2wsxA:9.69"],["5YJ1_K_6ELK501_0","PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"HIS A 141;TRP A 324;TRP A 147;TRP A 142","None;NM2 A1504 ( 4.6A);None;None","1.49A","5yj1k-2wsxA:undetectable;5yj1t-2wsxA:undetectable","5yj1k-2wsxA:12.84;5yj1t-2wsxA:12.84"],["5YJ1_T_6ELT501_0","PROTEIN CEREBLON","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",4,"TRP A 142;HIS A 141;TRP A 324;TRP A 147","None;None;NM2 A1504 ( 4.6A);None","1.43A","5yj1k-2wsxA:undetectable;5yj1t-2wsxA:undetectable","5yj1k-2wsxA:12.84;5yj1t-2wsxA:12.84"],["5ZJI_A_PQNA844_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1;PHOTOSYSTEM I REACTION CENTER SUBUNIT IX","2wsx","L-CARNITINE\/GAMMA-BUTYROBETAINE ANTIPORTER","Escherichia coli",5,"PHE A 286;GLY A 291;ALA A 136;LEU A 139;PHE A 411","None","1.44A","5zjiA-2wsxA:undetectable;5zjiJ-2wsxA:undetectable","5zjiA-2wsxA:9.48;5zjiJ-2wsxA:7.01"]]